    |
|
EXECUTIVE TEAM
r4 Vascular’s executive, development, and sales teams all have extensive clinical and business experience in vascular access and therapies requiring access, like chemotherapy, home infusion and dialysis. This experience enables us to make the right decisions on new technology development that has a real impact on efficacy, efficiency and cost of care. And we continue to keep abreast of the clinical and business needs of our customers to improve patient outcomes while containing cost.
Donald Geer, President
Vascular Access Centers, AngioDynamics, Bard Access Systems
Seasoned vascular access product development, technology identification, acquisition and marketing MBA, State University of New York at Albany
Ehab Ali, VP Sales
Cordis Cardiology, AngioDynamics
#1 Sales Representative in Country at Cordis and AngioDynamics,
President’s Club, hired and trained many sales personnel
B.S., Rutgers University/New Jersey Institute of Technology
Mark Kraus, VP Operations & Finance
Greatbatch, Inc, Enpath Medical, Medamicus, Inc.
A senior level start–up and operating executive. President, Delivery System Division at Enpath, General Manager of Introducer Business Unit, past COO and CTO.
B.S., Mechanical Engineering University of MN
Michael Hoch, VP Research & Development
Guidant Corp, Boston Scientific, Cordis (J&J)
Engineering Management, Principal Design Engineer, Program Management, Process Development – Vascular access leads and Angiographic products
M.M.E., Purdue University
Steve Allex, VP Product Development
Medtronic, Boston Scientific, Guidant
Management of Product Development, Manufacturing Engineering and Operations – Pacemakers, defibrillators, vascular leads, and catheter delivery systems
B.S., Mechanical Engineering SW State University
Laurie Lewandowski, Director, Quality & Regulatory
Affairs
Guidant Corp, Many management positions within Quality, Regulatory Affairs, Supplier Development and Customer Service.
M.B.A University of St. Thomas |
|
